XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 12,025 $ 13,198
Accounts receivable, net of allowance for credit losses and discounts & allowances of $1,640 and $1,270 at March 31, 2024 and December 31, 2023 respectively 15,064 13,875
Inventories, net 8,130 9,104
Prepaid expenses and other current assets 1,988 2,019
Refundable income taxes 378 0
Total current assets 37,585 38,196
Property, plant and equipment, net 24,627 22,764
Operating lease right-of-use asset 172 192
Goodwill 11,704 11,704
Intangible assets, net 6,763 6,898
Other assets 1,900 1,900
Total assets 82,751 81,654
Current liabilities    
Current portion of note payable 1,250 1,250
Accounts payable 10,024 9,976
Accrued expenses 3,604 4,916
Accrued income taxes 0 474
Total current liabilities 14,878 16,616
Note payable 1,235 1,483
Operating lease liabilities 102 118
Deferred income taxes, net 3,001 3,001
Total liabilities 19,216 21,218
Commitments and contingencies (Note 9)
Stockholders’ equity    
Preferred stock, no par value; 2,500 shares authorized; no shares issued or outstanding at March 31, 2024 and December 31, 2023 0 0
Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 14,691 outstanding at March 31, 2024 and December 31, 2023 6,509 6,509
Paid-in capital 5,498 4,825
Treasury stock, at cost (16,695) (16,695)
Retained earnings 68,223 65,797
Total stockholders' equity 63,535 60,436
Total liabilities and stockholders' equity $ 82,751 $ 81,654